Cough, Cold and Allergy (Hay Fever) Remedies in Uzbekistan

PROSPECTS

Growth in number of allergy sufferers due to environmental factors

According to the Ministry of Health of the Republic of Uzbekistan, even 15 years ago only 5-10% of the population suffered from allergies. Today, due to the impact of a variety of factors, this percentage has increased significantly.

Cough remedies mostly consumed in winter, especially by children

Whilst demand for allergy remedies increases in late spring, cough remedies are mainly consumed during the winter. Winters are cold in Uzbekistan, and therefore many people, especially children, catch colds during the colder winter months.

New interesting and effective launches set to boost sales

Due to new government regulations, many changes are expected in the pharmaceutical industry. Some brands are likely to leave the category, whilst new ones will make an entrance.

COMPETITIVE LANDSCAPE

Multinational Nycomed leads thanks to its long presence and good reputation

Nycomed Pharma maintained its leading position in cough, cold and allergy (hay fever) remedies in value terms in 2019, although it lost some share. The company benefits from its good reputation and long-standing presence in consumer health in the country.

Fervex sees higher sales than Coldrex, largely due to its lower price

Despite seeing share declines in 2019, Coldrex from GSK Consumer Healthcare and Fervex from Taisho Pharmaceutical Holdings continued to see value growth in cough, cold and allergy (hay fever) remedies. Coldrex powder in sachets is very well-known in the country.

Uzbekistani producers remain weak but have potential

Unlike in other OTC categories, in which Uzbekistani producers have increased their value shares by squeezing out foreign competitors, the situation in cough, cold and allergy (hay fever) remedies was different in 2019. Uzbekistani pharmaceutical companies remain very weak in the category.

Files are delivered directly into your account within a few minutes of purchase.